Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schernthaner

Showing results (1-10 of 315) with videos related to

Pageof 32
Sort By:
Klinische Wochenschrift|January 1, 1992
[Diabetic nephropathy in type 2 diabetes--epidemiology, early diagnosis and therapeutic strategies]G Schernthaner
Deutsche Medizinische Wochenschrift (1946)|December 2, 2006
[Success of blood pressure reduction in diabetic patients]G Schernthaner
Wiener Medizinische Wochenschrift (1946)|April 15, 1985
[Etiology and pathophysiology of the diabetes mellitus syndromes]G Schernthaner
International Journal of Clinical Practice|June 4, 2009
Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factorsG Schernthaner
Diabetic Medicine : a Journal of the British Diabetic Association|July 20, 2010
Fixed-dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient careG Schernthaner
Deutsche Medizinische Wochenschrift (1946)|July 16, 1982
[Glycohemoglobin (HbA1): a valuable parameter for the evaluation of long-term control of diabetes]G Schernthaner
Deutsche Medizinische Wochenschrift (1946)|October 12, 1984
[Plasmapheresis--an enrichment in the therapy of autoimmune endocrinopathies?]G Schernthaner
Diabetes Care|December 1, 1993
Immunogenicity and allergenic potential of animal and human insulinsG Schernthaner
Diabetes Care|November 1, 1982
Affinity of IgG-insulin antibodies to human (recombinant DNA) insulin and porcine insulin in insulin-treated diabetic individuals with and without insulin resistanceG Schernthaner
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 1, 1995
Progress in the immunointervention of type-1 diabetes mellitusG Schernthaner
Pageof 32

Showing results (1-10 of 315) with videos related to

Sort By:
Pageof 32
Klinische Wochenschrift|January 1, 1992
[Diabetic nephropathy in type 2 diabetes--epidemiology, early diagnosis and therapeutic strategies]G Schernthaner
Deutsche Medizinische Wochenschrift (1946)|December 2, 2006
[Success of blood pressure reduction in diabetic patients]G Schernthaner
Wiener Medizinische Wochenschrift (1946)|April 15, 1985
[Etiology and pathophysiology of the diabetes mellitus syndromes]G Schernthaner
International Journal of Clinical Practice|June 4, 2009
Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factorsG Schernthaner
Diabetic Medicine : a Journal of the British Diabetic Association|July 20, 2010
Fixed-dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient careG Schernthaner
Deutsche Medizinische Wochenschrift (1946)|July 16, 1982
[Glycohemoglobin (HbA1): a valuable parameter for the evaluation of long-term control of diabetes]G Schernthaner
Deutsche Medizinische Wochenschrift (1946)|October 12, 1984
[Plasmapheresis--an enrichment in the therapy of autoimmune endocrinopathies?]G Schernthaner
Diabetes Care|December 1, 1993
Immunogenicity and allergenic potential of animal and human insulinsG Schernthaner
Diabetes Care|November 1, 1982
Affinity of IgG-insulin antibodies to human (recombinant DNA) insulin and porcine insulin in insulin-treated diabetic individuals with and without insulin resistanceG Schernthaner
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 1, 1995
Progress in the immunointervention of type-1 diabetes mellitusG Schernthaner
Pageof 32